Soligenix (SNGX)
(Delayed Data from NSDQ)
$3.87 USD
0.00 (0.05%)
Updated Sep 24, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
Soligenix Inc. [SNGX]
Reports for Purchase
Showing records 1 - 20 ( 98 total )
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Buy: Q2 In Line. Quarter Billion Revenue Opportunity in Sight.
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Neutral Rated: Cash on the Balance Sheet but few Events in 2022
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Neutral: SGX301 Delayed Until H2-2022 Company Blames Covid
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Neutral: Can SGX301 Save the Company? We Don?t Think So.
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Neutral: SGX942 in Mucositis Fails - We Kind of Thought So
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Neutral: Raises Cash by Selling Stock with ATM Facility
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Neutral : Model Updated for Dilution, Lowering to Neutral
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Company: Soligenix Inc.
Industry: Medical - Biomedical and Genetics
Reports the Quarter with Multiple Catalysts Ahead
Provider: DAWSON JAMES SECURITIES, INC.
Analyst: KOLBERT J